Licensing deals

A close-up view of a jigsaw puzzle with a missing piece
Biotech

Novo Holdings-backed biotech raises $205M to fill gout care gap

Crystalys and its team of 10 people—and growing—is pushing ahead in hopes of filling the treatment gap for patients with gout.
Gabrielle Masson Sep 30, 2025 8:00am
Glowing puzzle piece fitting into puzzle

Gilead pumps up virology pipeline with drug transporter deal

Sep 29, 2025 10:35am
HPE conf

US biotechs thinking twice about licensing drugs to Europe

Sep 26, 2025 8:09am
research deal two people shaking hands in lab

Merck opts in on Evaxian's preclinical vaccine candidate

Sep 25, 2025 7:00am
increase

Biopharma biobucks decline, while upfront deal payments rise

Sep 24, 2025 11:30am
Bicycle bike ride travel

Cyclerion emerges from latest pivot as neuro biotech

Sep 24, 2025 4:15am